e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD
Session:
Biomarkers and phenotypes of COPD
Session type:
Thematic Poster
Number:
3661
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic. Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD. Eur Respir J 2016; 48: Suppl. 60, 3661
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Microparticles in stable and exacerbated COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Determinants of heightened systemic inflammation at exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Increased small intestinal permeability during severe acute exacerbations of COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Local and systemic inflammation in acute viral exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept